TG Therapeutics, Inc.
Status: Publicly traded
Direct answer
TG Therapeutics, Inc. is publicly traded on NASDAQ under the ticker TGTX.
Based in New York City and established in 1993, TG Therapeutics, Inc. is a biopharmaceutical company that has advanced to the commercial stage. Its core mission revolves around the acquisition, advancement, and marketing of novel therapeutic solutions. The company's focus areas specifically include B-cell related cancers (malignancies) and various autoimmune disorders. Among its significant investigational...
Can you invest in TG Therapeutics, Inc.?
Yes. TG Therapeutics, Inc. is publicly traded on NASDAQ under the ticker TGTX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for TG Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.